JPRN-jRCTs041190022
Recruiting
Phase 2
Multicenter randomized controlled trial to study the efficacy of multidonor fecal microbiota transplantation for Crohn's disease
Ohmiya Naoki0 sites50 target enrollmentApril 22, 2019
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Crohn's disease
- Sponsor
- Ohmiya Naoki
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with active Crohn's disease (CDAI 150 or more)
Exclusion Criteria
- •1\.past history of allergy to drugs used in this study
- •2\.possible of documented pregnant women
- •3\.patients with fistula, penetration, and perforation except anal fistula
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Multi-center, randomized clinical trial to study the impact of in-hospital guidance for acutely decompensated heart failure treatment by predefined NT-proBNP targets (>30% reduction in NT-proBNP during admission) on the reduction of readmission rates and mortalityacutely decompensated heart failurecongestive heart failure10019280NL-OMON44072Academisch Medisch Centrum362
Not yet recruiting
Not Applicable
A multicenter randomized controlled trial on the treatment of snake string ulcer with liver and gallbladder fire excess syndrome usingITMCTR2024000117liuzhiyong
Completed
Not Applicable
Multicenter randomized controlled trial exploring postoperative complications and mobilization following major abdominal surgery with vs. without fitness tracker-based feedback (EXPELLIARMUS) - a CHIR-Net Student-Initiated German Medical Audit trial (CHIR-Net SIGMA trial)DRKS00016755niversitätsklinikum Ulm348
Recruiting
Not Applicable
Multi-center randomized controlled trial to evaluate oral vitamin B12 treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patientsgastric cancerJPRN-UMIN000030727yokohama city university160
Not yet recruiting
Not Applicable
Download Useful Kind of App for Your Health Studymetabolic syndromeJPRN-UMIN000042986Japan Agency for Medical Research and Development1,000